Search research articles
Contact Us
Filters
Showing results (51-60 of 95) with videos related to
Page
of 10
Sort By:
Clinical and Experimental Medicine
|
May 8, 2025
Transient increase in mitochondrial respiration in blood cells from breast cancer patients following chemo- and radiotherapy
Marie-Louise Abrahamsen, Ida Bager Christensen, Linda Laizāne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 16, 2011
Gemcitabine plus docetaxel versus docetaxel in patients with predominantly human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: a randomized, phase III study by the Danish Breast Cancer Cooperative Group
Dorte Lisbet Nielsen, Karsten D Bjerre, Erik H Jakobsen, et al.
Acta Oncologica (Stockholm, Sweden)
|
February 9, 2011
Dose-tailoring of FEC adjuvant chemotherapy based on leukopenia is feasible and well tolerated. Toxicity and dose intensity in the Scandinavian Breast Group phase 3 adjuvant Trial SBG 2000-1
Per Edlund, Johan Ahlgren, Karsten Bjerre, et al.
Breast Cancer Research and Treatment
|
August 8, 2020
Patterns in detection of recurrence among patients treated for breast cancer
Lena Saltbæk, Trine Allerslev Horsboel, Birgitte Vrou Offersen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2010
Phase III randomized study comparing docetaxel plus trastuzumab with vinorelbine plus trastuzumab as first-line therapy of metastatic or locally advanced human epidermal growth factor receptor 2-positive breast cancer: the HERNATA study
Michael Andersson, Elisabeth Lidbrink, Karsten Bjerre, et al.
Acta Oncologica (Stockholm, Sweden)
|
August 1, 2017
The effects of individually tailored nurse navigation for patients with newly diagnosed breast cancer: a randomized pilot study
Birgitte Goldschmidt Mertz, Anne Katrine Dunn-Henriksen, Niels Kroman, et al.
Environmental Research
|
April 12, 2024
Aqueous mineral carbonation of three different industrial steel slags: Absorption capacities and product characterization
Emmanouela Leventaki, Eduarda Couto Queiroz, Shyam Krishnan Pisharody, et al.
Breast Cancer Research and Treatment
|
January 16, 2007
Leukemia following breast cancer: an international population-based study of 376,825 women
Regan A Howard, Ethel S Gilbert, Bingshu E Chen, et al.
Acta Oncologica (Stockholm, Sweden)
|
April 30, 2020
Leukocyte nadir as a predictive factor for efficacy of adjuvant chemotherapy in breast cancer. Results from the prospective trial SBG 2000-1
Paula Poikonen-Saksela, Henrik Lindman, Asgerdur Sverrisdottir, et al.
Breast Cancer Research and Treatment
|
February 6, 2007
Risk of second non-hematological malignancies among 376,825 breast cancer survivors
Linda Morris Brown, Bingshu E Chen, Ruth M Pfeiffer, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 95) with videos related to
Sort By:
Page
of 10
Clinical and Experimental Medicine
|
May 8, 2025
Transient increase in mitochondrial respiration in blood cells from breast cancer patients following chemo- and radiotherapy
Marie-Louise Abrahamsen, Ida Bager Christensen, Linda Laizāne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 16, 2011
Gemcitabine plus docetaxel versus docetaxel in patients with predominantly human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: a randomized, phase III study by the Danish Breast Cancer Cooperative Group
Dorte Lisbet Nielsen, Karsten D Bjerre, Erik H Jakobsen, et al.
Acta Oncologica (Stockholm, Sweden)
|
February 9, 2011
Dose-tailoring of FEC adjuvant chemotherapy based on leukopenia is feasible and well tolerated. Toxicity and dose intensity in the Scandinavian Breast Group phase 3 adjuvant Trial SBG 2000-1
Per Edlund, Johan Ahlgren, Karsten Bjerre, et al.
Breast Cancer Research and Treatment
|
August 8, 2020
Patterns in detection of recurrence among patients treated for breast cancer
Lena Saltbæk, Trine Allerslev Horsboel, Birgitte Vrou Offersen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2010
Phase III randomized study comparing docetaxel plus trastuzumab with vinorelbine plus trastuzumab as first-line therapy of metastatic or locally advanced human epidermal growth factor receptor 2-positive breast cancer: the HERNATA study
Michael Andersson, Elisabeth Lidbrink, Karsten Bjerre, et al.
Acta Oncologica (Stockholm, Sweden)
|
August 1, 2017
The effects of individually tailored nurse navigation for patients with newly diagnosed breast cancer: a randomized pilot study
Birgitte Goldschmidt Mertz, Anne Katrine Dunn-Henriksen, Niels Kroman, et al.
Environmental Research
|
April 12, 2024
Aqueous mineral carbonation of three different industrial steel slags: Absorption capacities and product characterization
Emmanouela Leventaki, Eduarda Couto Queiroz, Shyam Krishnan Pisharody, et al.
Breast Cancer Research and Treatment
|
January 16, 2007
Leukemia following breast cancer: an international population-based study of 376,825 women
Regan A Howard, Ethel S Gilbert, Bingshu E Chen, et al.
Acta Oncologica (Stockholm, Sweden)
|
April 30, 2020
Leukocyte nadir as a predictive factor for efficacy of adjuvant chemotherapy in breast cancer. Results from the prospective trial SBG 2000-1
Paula Poikonen-Saksela, Henrik Lindman, Asgerdur Sverrisdottir, et al.
Breast Cancer Research and Treatment
|
February 6, 2007
Risk of second non-hematological malignancies among 376,825 breast cancer survivors
Linda Morris Brown, Bingshu E Chen, Ruth M Pfeiffer, et al.
Page
of 10